Products Categories
CAS No.: | 314-35-2 |
---|---|
Name: | etamiphyllin |
Article Data: | 18 |
Molecular Structure: | |
Formula: | C13H21 N5 O2 |
Molecular Weight: | 279.342 |
Synonyms: | Theophylline,7-[2-(diethylamino)ethyl]- (6CI,7CI,8CI); 1,3-Dimethyl-7-(2-diethylaminoethyl)xanthine;7-(2-Diethylaminoethyl)-1,3-dimethylxanthine;7-(2-Diethylaminoethyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione;7-(Diethylaminoethyl)theophylline; 7-[2-(Diethylamino)ethyl]theophylline;Corafil; Dietamiphylline; Diethylaminoethyltheophylline; Etaminophylline;Etamiphyllin; Etamiphylline; Milliphylline; Millophyline; NSC 38348;Parephyllin; Queryl; R 3588; Soluphyline; Soluphylline |
Density: | 1.24g/cm3 |
Melting Point: | 75° |
Boiling Point: | 460.2°Cat760mmHg |
Flash Point: | 232.1°C |
Safety: | Poison by subcutaneous and intraperitoneal routes. Moderately toxic by ingestion. When heated to decomposition it emits toxic fumes of NOx. |
PSA: | 65.06000 |
LogP: | -0.22450 |
IUPAC Name: 7-(2-Diethylaminoethyl)-1,3-dimethylpurine-2,6-dione
Synonyms of Corafil (CAS NO.314-35-2) : 1,3-Dimethyl-7-(2-diethylaminoethyl)xanthine ; 1H-Purine-2,6-dione, 7-[2- (diethylamino)ethyl]-3,7-dihydro-1,3-dimethyl- ; 7-(2-Diethylaminoethyl)-1,3-dimethylxanthine ; 7-[2-(Diethylamino)ethyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione ; Dietamiphylline
InChI:InChI=1/C13H21N5O2/c1-5-17(6-2)7-8-18-9-14-11-10(18)12(19)16(4)13(20)15(11)3/h9H,5-8H2,1-4H3
CAS NO:314-35-2
Molecular Formula:C13H21N5O2
Molecular Weight :279.3381
Molecular Structure :
EINECS: 206-244-6
Index of Refraction: 1.605
Surface Tension: 46.3 dyne/cm
Density: 1.24 g/cm3
Flash Point: 232.1 °C
Enthalpy of Vaporization: 72.08 kJ/mol
Boiling Point: 460.2 °C at 760 mmHg
Vapour Pressure: 1.19E-08 mmHg at 25°C
Corafil (CAS NO.314-35-2) is used as respiratory asthma drug.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 254mg/kg (254mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 116, Pg. 343, 1956. | |
mouse | LD50 | oral | 1237mg/kg (1237mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 116, Pg. 343, 1956. | |
mouse | LD50 | subcutaneous | 182mg/kg (182mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Arzneimittel-Forschung. Drug Research. Vol. 4, Pg. 649, 1954. |
women | TDLo | oral | 240mg/kg (240mg/kg) | SENSE ORGANS AND SPECIAL SENSES: CHANGE IN OLFACTORY NERVE: OLFACTION BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD CARDIAC: CHANGE IN RATE | Human & Experimental Toxicology. Vol. 9, Pg. 201, 1990. |
Poison by subcutaneous and intraperitoneal routes. Moderately toxic by ingestion. When Corafil (CAS NO.314-35-2) is heated to decomposition, it emits toxic fumes of NOx.